Hepatic versus extrahepatic expression of CYP3A30 and CYP3A56 in adult killifish (Fundulus heteroclitus).

Aquat Toxicol

Department of Zoophysiology, Göteborg University, Box 463, SE-40530 Göteborg, Sweden.

Published: August 2003

Members of the CYP3A subfamily represent the largest portion of CYP proteins in liver and intestine in vertebrates. The CYP3A enzymes are involved in metabolic clearance of numerous chemically diverse compounds including toxins, carcinogens, pesticides, therapeutic drugs, dietary products and hormones. Most studies of CYP3A have been performed in mammals, whereas relatively little is known of that in non-mammalian species. We have investigated CYP3A expression in the marine and estuarine killifish (Fundulus heteroclitus). We isolated a novel CYP3A cDNA sequence, denoted CYP3A56, from killifish intestine. The CYP3A56 sequence shared 98% nucleotide and amino acid sequence identity with CYP3A30, previously isolated from killifish liver. We hypothesize that a recent gene duplication event has occurred within the killifish CYP3A subfamily. The CYP3A30 and CYP3A56 genes were co-expressed in liver, intestine, gill, kidney, spleen, brain and ovary in several individuals. The hepatic versus extrahepatic CYP3A30/56 mRNA expression was analyzed in adult killifish of both sexes, using conventional as well as real-time semi-quantitative RT-PCR. Tissues expressing CYP3A30/56 mRNA were in a descending order of magnitude: liver>intestine>>gill>spleen>kidney>brain. Furthermore, inter-individual differences (up to 18%) in CYP3A30/56 mRNA expression were evident in killifish, in particular in extrahepatic organs. For comparison, CYP3A protein expression levels were determined using polyclonal antibodies (PAb) against rainbow trout (Oncorhynchus mykiss) CYP3A. Sexually dimorphic expression of hepatic and extrahepatic CYP3A30/56 mRNA and CYP3A proteins was observed in killifish. For example, males displayed up to 2.5-fold higher CYP3A protein expression compared with females. In agreement with CYP3A30/56 mRNA analysis, highest CYP3A protein levels were observed in liver and intestine. Low CYP3A protein levels were seen in gill, kidney and spleen. Cellular localization of CYP3A protein expression was investigated using immunohistochemistry analysis and PAb against rainbow trout CYP3A. Strong CYP3A protein staining was seen in intestinal enterocytes, in gill filaments and in renal tubular epithelial cells. Moderate CYP3A staining was seen in hepatocytes in the liver, whereas mild staining was observed in hematopoietic cells in the spleen and in follicles in the ovary. Thus, similar to mammals, CYP3A expression in fish is prominent in the digestive- and respiratory tracts and may be important for the first-pass metabolism of xenobiotics. Moreover, CYP3A expression also is evident in brain and ovary in killifish, which suggests a role for CYP3A enzymes in biotransformation of xenobiotics and fine-tuning levels of steroid hormones in situ in extrahepatic organs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0166-445x(03)00057-2DOI Listing

Publication Analysis

Top Keywords

cyp3a protein
24
cyp3a30/56 mrna
20
cyp3a
19
liver intestine
12
cyp3a expression
12
protein expression
12
expression
10
killifish
9
hepatic versus
8
versus extrahepatic
8

Similar Publications

Fullerenols, a water-soluble polyhydroxy derivative of fullerene, hold promise in medical and materials science due to their unique properties. However, concerns about their potential embryotoxicity remain. Using a pregnancy mouse model and metabolomics analysis, our findings reveal that fullerenols exposure during pregnancy not only significantly reduced mice placental weight and villi thickness, but also altered the classes and concentrations of metabolites in the mouse placenta.

View Article and Find Full Text PDF

Cytochrome P450 (CYP) 3A4 plays a major role in drug metabolism. Its activity could be determined by non-invasive and cost-effective assays, such as breath analysis, for the personalised monitoring of drug response. For the first time, we identify an isotopically unlabelled CYP3A4 substrate, tolterodine that leads to the formation of a non-toxic volatile metabolite, acetone, which could potentially be applied to monitor CYP3A4 activity in humans.

View Article and Find Full Text PDF

Single nucleotide polymorphisms (SNPs) represent the prevailing form of genetic variations observed in the human population. Such variations could alter the encoded enzymes' activities. CYP3A4/5 enzymes are involved in metabolizing drugs, notably antivirals against SARS-CoV-2.

View Article and Find Full Text PDF

Tacrolimus is metabolized in the liver with the participation of cytochrome P450 isoforms 3A4 and 3A5 (CYP3A4, CYP3A5). Omeprazole, unlike famotidine, is a substrate and inhibitor of CYP2C19, CYP3A4, CYP3A5 enzymes. The aim of the study is to compare the effect of omeprazole and famotidine on the tacrolimus concentration and the kidney transplant function.

View Article and Find Full Text PDF

A new series of 13 ritonavir-like inhibitors of human drug-metabolizing CYP3A4 was rationally designed to study the R side-group and R end-group interplay when the R side-group is represented by phenyl. Spectral, functional, and structural characterization showed no improvement in the binding affinity and inhibitory potency of R/R-phenyl inhibitors upon elongation and/or fluorination of R-Boc (tert-butyloxycarbonyl) or its replacement with benzenesulfonyl. When R is pyridine, the impact of R-phenyl-to-indole/naphthalene substitution was multidirectional and highly dependent on side-group stereo configuration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!